161 related articles for article (PubMed ID: 21425306)
1. Nucleolar aggresomes as counterparts of cytoplasmic aggresomes in proteotoxic stress. Proteasome inhibitors induce nuclear ribonucleoprotein inclusions that accumulate several key factors of neurodegenerative diseases and cancer.
Latonen L
Bioessays; 2011 May; 33(5):386-95. PubMed ID: 21425306
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibitors induce nucleolar aggregation of proteasome target proteins and polyadenylated RNA by altering ubiquitin availability.
Latonen L; Moore HM; Bai B; Jäämaa S; Laiho M
Oncogene; 2011 Feb; 30(7):790-805. PubMed ID: 20956947
[TBL] [Abstract][Full Text] [Related]
3. The nuclear ubiquitin-proteasome system: visualization of proteasomes, protein aggregates, and proteolysis in the cell nucleus.
von Mikecz A; Chen M; Rockel T; Scharf A
Methods Mol Biol; 2008; 463():191-202. PubMed ID: 18951170
[TBL] [Abstract][Full Text] [Related]
4. Reactive nucleolar and Cajal body responses to proteasome inhibition in sensory ganglion neurons.
Palanca A; Casafont I; Berciano MT; Lafarga M
Biochim Biophys Acta; 2014 Jun; 1842(6):848-59. PubMed ID: 24269586
[TBL] [Abstract][Full Text] [Related]
5. The aggravating role of the ubiquitin-proteasome system in neurodegeneration.
Ardley HC; Hung CC; Robinson PA
FEBS Lett; 2005 Jan; 579(3):571-6. PubMed ID: 15670810
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin-A-induced prion protein aggresomes are dynamic quality-control cellular compartments.
Ben-Gedalya T; Lyakhovetsky R; Yedidia Y; Bejerano-Sagie M; Kogan NM; Karpuj MV; Kaganovich D; Cohen E
J Cell Sci; 2011 Jun; 124(Pt 11):1891-902. PubMed ID: 21558416
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-proteasome pathway in Parkinson's disease and other neurodegenerative diseases.
Ross CA; Pickart CM
Trends Cell Biol; 2004 Dec; 14(12):703-11. PubMed ID: 15564047
[TBL] [Abstract][Full Text] [Related]
8. Amyloid precursor protein accumulates in aggresomes in response to proteasome inhibitor.
Dehvari N; Mahmud T; Persson J; Bengtsson T; Graff C; Winblad B; Rönnbäck A; Behbahani H
Neurochem Int; 2012 Apr; 60(5):533-42. PubMed ID: 22366649
[TBL] [Abstract][Full Text] [Related]
9. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair.
Bergink S; Severijnen LA; Wijgers N; Sugasawa K; Yousaf H; Kros JM; van Swieten J; Oostra BA; Hoeijmakers JH; Vermeulen W; Willemsen R
Neurobiol Dis; 2006 Sep; 23(3):708-16. PubMed ID: 16860562
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor SHIP1 colocalizes in nucleolar cavities with p53 and components of PML nuclear bodies.
Ehm P; Nalaskowski MM; Wundenberg T; Jücker M
Nucleus; 2015; 6(2):154-64. PubMed ID: 25723258
[TBL] [Abstract][Full Text] [Related]
12. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease.
Grune T; Jung T; Merker K; Davies KJ
Int J Biochem Cell Biol; 2004 Dec; 36(12):2519-30. PubMed ID: 15325589
[TBL] [Abstract][Full Text] [Related]
13. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
Matsuda N; Tanaka K
J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
[TBL] [Abstract][Full Text] [Related]
14. Protein ubiquitination, degradation and the proteasome in neuro-degenerative disorders: no clear evidence for a significant pathogenetic role of proteasome failure in Alzheimer disease and related disorders.
Schmitt HP
Med Hypotheses; 2006; 67(2):311-7. PubMed ID: 16580788
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
[TBL] [Abstract][Full Text] [Related]
16. Aggresome formation.
Corboy MJ; Thomas PJ; Wigley WC
Methods Mol Biol; 2005; 301():305-27. PubMed ID: 15917642
[TBL] [Abstract][Full Text] [Related]
17. Fluorescent reporters for the ubiquitin-proteasome system.
Salomons FA; Verhoef LG; Dantuma NP
Essays Biochem; 2005; 41():113-28. PubMed ID: 16250901
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.
Paul S
Bioessays; 2008 Nov; 30(11-12):1172-84. PubMed ID: 18937370
[TBL] [Abstract][Full Text] [Related]
19. Aggresomes do not represent a general cellular response to protein misfolding in mammalian cells.
Beaudoin S; Goggin K; Bissonnette C; Grenier C; Roucou X
BMC Cell Biol; 2008 Oct; 9():59. PubMed ID: 18937858
[TBL] [Abstract][Full Text] [Related]
20. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
Hatakeyama S
Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
